These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 11416781)
21. Hormone replacement therapy regimens and breast cancer risk(1). Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157 [TBL] [Abstract][Full Text] [Related]
22. Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer. Zahl PH; Mæhlen J PLoS One; 2015; 10(5):e0124076. PubMed ID: 25938446 [TBL] [Abstract][Full Text] [Related]
23. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. Colditz GA J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169 [TBL] [Abstract][Full Text] [Related]
24. Type of hormone therapy and risk of misclassification at mammography screening. Njor SH; Hallas J; Schwartz W; Lynge E; Pedersen AT Menopause; 2011 Feb; 18(2):171-7. PubMed ID: 20729766 [TBL] [Abstract][Full Text] [Related]
25. Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study. Rosenberg LU; Granath F; Dickman PW; Einarsdóttir K; Wedrén S; Persson I; Hall P Breast Cancer Res; 2008; 10(5):R78. PubMed ID: 18803850 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of hormone profile in women during the pre- and postmenopausal period using hormone replacement therapy, and analysis of the mammography image in these women]. Niesłuchowska-Frydrych B; Dworniak T; Iwaszkiewicz K; Marianowski L Ginekol Pol; 2001 Apr; 72(4):217-23. PubMed ID: 11444178 [TBL] [Abstract][Full Text] [Related]
27. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Séradour B; Allemand H; Weill A; Ricordeau P Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691 [TBL] [Abstract][Full Text] [Related]
28. Influence of estrogen plus testosterone supplementation on breast cancer. Ness RB; Albano JD; McTiernan A; Cauley JA Arch Intern Med; 2009 Jan; 169(1):41-6. PubMed ID: 19139322 [TBL] [Abstract][Full Text] [Related]
29. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Swedish Organised Service Screening Evaluation Group Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585 [TBL] [Abstract][Full Text] [Related]
30. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324 [TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect. Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M; Patnick J Breast Cancer Res; 2006; 8(1):R8. PubMed ID: 16417651 [TBL] [Abstract][Full Text] [Related]
32. Predictors of breast density change after hormone therapy cessation: results from a randomized trial. Lowry SJ; Aiello Bowles EJ; Anderson ML; Buist DS Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2309-12. PubMed ID: 21813728 [TBL] [Abstract][Full Text] [Related]
33. Recording of hormone therapy and breast density in breast screening programs: summary and recommendations of the International Cancer Screening Network. Cox B; Ballard-Barbash R; Broeders M; Dowling E; Malila N; Shumak R; Taplin S; Buist D; Miglioretti D; Breast Cancer Res Treat; 2010 Dec; 124(3):793-800. PubMed ID: 20414718 [TBL] [Abstract][Full Text] [Related]
34. The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristics. Masala G; Assedi M; Caini S; Ermini I; Occhini D; Castaldo M; Bendinelli B; Zagni D; Tanzini D; Saieva C; Ambrogetti D; Palli D Tumori; 2014; 100(4):377-85. PubMed ID: 25296586 [TBL] [Abstract][Full Text] [Related]
35. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392 [TBL] [Abstract][Full Text] [Related]
36. Influence of hormone replacement therapy on the accuracy of screening mammography. Vernet Mdel M; Checa MA; Macià F; Casamitjana M; Carreras R Breast J; 2006; 12(2):154-8. PubMed ID: 16509841 [TBL] [Abstract][Full Text] [Related]
37. Dietary carbohydrates and breast cancer risk: a prospective study of the roles of overall glycemic index and glycemic load. Silvera SA; Jain M; Howe GR; Miller AB; Rohan TE Int J Cancer; 2005 Apr; 114(4):653-8. PubMed ID: 15609324 [TBL] [Abstract][Full Text] [Related]
38. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. Robbins AS; Clarke CA J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938 [No Abstract] [Full Text] [Related]
39. Current breast cancer risks of hormone replacement therapy in postmenopausal women. Shah NR; Wong T Expert Opin Pharmacother; 2006 Dec; 7(18):2455-63. PubMed ID: 17150001 [TBL] [Abstract][Full Text] [Related]
40. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. Laya MB; Larson EB; Taplin SH; White E J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]